Sidley Austin represented Roche in the transaction, and Cooley represented Poseida Therapeutics. Roche, one of the world’s largest biotechnology companies and the global leader in in-vitro...
Roche’s $1.5 Billion Acquisition of Poseida Therapeutics
DraftKings’ $750 Million Acquisition of Jackpocket
Sullivan & Cromwell represented DraftKings, while Cooley represented Jackpocket in the transaction. DraftKings, a digital sports entertainment and gaming company, has reached an agreement to acquire...
Battery Ventures’ Acquisition of GrammaTech’s Software Products
Cooley advised Battery Ventures on the deal. GrammaTech announced that Battery Ventures has acquired its software products division, including the CodeSonar and CodeSentry product lines. The...
Celadon Partners’ $38 Million Acquisition of Senti Bio’s Assets
Morrison Foerster advised Celadon Partners and GeneFab, while Cooley and Goodwin Procter advised Senti Biosciences. Senti Biosciences, Inc. (Nasdaq: SNTI) and Celadon Partners, LLC announced a transaction...
TransMedics Group’s Acquisition of Organ Support and Heart Preservation Transport System Assets from Bridge to Life
Ropes & Gray acted as legal advisor to TransMedics, and Cooley acted as legal advisor to Bridge to Life. TransMedics Group, Inc. (Nasdaq: TMDX) announced that is...
Midwestern Electric’s Acquisition of Kuharchik Construction and Wyoming Electric & Signals
Cooley advised Midwestern Electric on the deal. Midwestern Electric (MWE), a portfolio company of Canada-based private equity firm CAI Capital Partners, announced its acquisition of Kuharchik...
ThoughtSpot’s $200 Million Acquisition of Mode Analytics
Cooley advises ThoughtSpot on the deal. ThoughtSpot announced it has signed a definitive agreement to acquire Mode Analytics in a cash and equity deal valued at $200...
Veritone’s $52 Million Acquisition of Broadbean
Cooley is acting as legal counsel to Veritone, and Sidley Austin is acting as legal counsel to Career Builder. Veritone, Inc. (NASDAQ: VERI) announced its agreement...
Angion’s Merger Agreement with Elicio Therapeutics
Cooley advised Angion on the deal. Angion, a clinical-stage biopharmaceutical company, announced its definitive merger agreement with Elicio Therapeutics. Elicio will merge with a wholly owned subsidiary...
Kite’s Acquisition of Tmunity
Cooley advised Tmunity on the deal. Tmunity, a clinical-stage biotechnology company, announced its agreement to sell to Kite, a global biopharmaceutical company. The acquisition will provide...
Amgen’s Acquisition of Horizon Therapeutics
Cooley LLP and Matheson LLP advised Horizon, while Sullivan & Cromwell LLP and William Fry LLP advised Amgen. Debevoise & Plimpton LLP advised JP Morgan. Macfarlanes...
AstraZeneca’s Acquisition of Neogene Therapeutics
Cooley advised Neogene Therapeutics on the deal. Neogene Therapeutics, a global clinical-stage biotechnology company, signed its definitive agreement to be acquired by AstraZeneca for a total consideration...